⌘K

Login Start Free

Home/Filings/4/0001209191-18-046825

4//SEC Filing

Degnan Chris 4

Accession 0001209191-18-046825

CIK 0001660334other

View on SEC.gov Company Profile

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 4:47 PM ET

Size

4.6 KB

Accession

0001209191-18-046825

Insider Transaction Report

Form 4

Period: 2018-06-19

Verrica Pharmaceuticals Inc.VRCA

Chief Financial Officer

Transactions

Purchase
Common Stock
2018-06-19$15.00/sh+3,000$45,000→ 3,000 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Verrica Pharmaceuticals Inc.

CIK 0001660334

Entity typeother

Related Parties

1

filerCIK 0001741968

Filing Metadata

Form type: 4
Filed: Aug 14, 8:00 PM ET
Accepted: Aug 15, 4:47 PM ET
Size: 4.6 KB

View on SEC.gov